NDB is a selective human FXRalpha (hFXRalpha) antagonist that is effective in modulating transcription of FXRalpha downstream genes. NDB can be used in anti-diabetes research[1].
Molecular Weight:
471.42
Purity:
98.36
CAS Number:
[1660153-08-1]
Formula:
C26H28Cl2N2O2
Target:
FXR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted